Navigation Links
Swype Cold & Flu Shield Significantly Reduces Occurrence of Colds in Clinical Study

PONTE VEDRA BEACH, Fla., Sept. 27, 2011 /PRNewswire/ -- Nuance Health today announced the results of an eight-week clinical study that was conducted on their innovative product, Swype Cold & Flu Shield, during the 2010-11 cold and flu season.  

The clinical study, conducted on 103 volunteers who identified themselves as typically susceptible to colds, evaluated the effectiveness, tolerability, and willingness of participants to use a nasal gel to prevent illness.  In previous testing performed by an independent microbiology laboratory, the active ingredients in Swype have been shown to kill over 99.9% of all 25 cold and flu viruses tested including 15 serotypes of rhinovirus and swine influenza (H1N1).  In the study, participants were instructed to use Swype three times daily for eight weeks during the cold and flu season.  The volunteers reported actual use of the product and cold symptoms via weekly email surveys.

The results of the clinical study were outstanding.  Over 83% of volunteers used Swype two or three times per day during the study, an excellent compliance rate for a prophylactic product (fewer people wash their hands after using the bathroom).  In a typical cold and flu season, about 45% of participants would have experienced moderate or stronger cold symptoms during an eight-week period, but only 2% of Swype users reported more than mild cold symptoms.  Overall, users of Swype experienced about 70% fewer colds than anticipated, an unprecedented result for a cold prevention product.

Volunteers in the study offered unprompted praise for Swype Cold & Flu Shield: "I love Swype and tell many about your product," "Overall the product is invisible, light, and easy to use," "Everyone around me is sick, but not me," and "I actually had a cold when I started using Swype and within one day it was gone" are examples of comments posted by Swype users.

"I am very excited about the results of this study," said Dr. Kent New, the creator of Swype and a physician with a PhD in Microbiology and Immunology.  "No other cold prevention product on the market has results comparable to what we have been able to demonstrate with Swype.  By using Swype to kill virus on the skin at the entrance to your nose, you are significantly reducing the chance you catch a cold or flu.  In addition, about 85% of participants reported they would continue to use the product and recommend it to friends, indicating Swype is easy to use and effective."

Swype Cold & Flu Shield is available on the Swype website (  A tube that lasts approximately 2 months costs $12.99.  Nuance Health is currently offering 20% off orders by using code "CLIN20".  

For more information about Swype, visit

About Nuance Health

Nuance Health was started by a physician and his wife. Together, they use their understanding of science to develop safe and effective products that help people maintain good health.  

Jim McDonald
877-367-7997 x704

SOURCE Nuance Health
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Nuance Health Introduces Swype, an Innovative New Product Designed to Enhance Defense Against Colds and Flu
2. Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays
3. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
4. Tata Interactive Systems Partners With Bersin & Associates for Exclusive Executive Learning Forum - TLF 2009
5. Sigma-Aldrich (Nasdaq: SIAL) Announces Appointment of George Miller as Sr. Vice President, General Counsel & Secretary
6. Robbins & Myers Announces Regular Quarterly Cash Dividend
7. Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
8. Frost & Sullivan Lauds Viatronix as European Medical Imaging Emerging Company of the Year
9. Bausch & Lomb Acquires the Commercial Assets of Italian Ophthalmic Pharmaceuticals Company Tubilux
10. Robbins & Myers Announces Fourth Quarter and Full Year 2009 Results
11. Dynatronics Appoints Douglas Sampson as Vice President of Production and Research & Development
Post Your Comments:
(Date:6/24/2016)... , Belgium , June ... MKT: VNRX), today announced the appointment of Dr. ... of Directors as a Non-Executive Director, effective June ... Company,s Audit, Compensation and Nominations and Governance Committees.  ... Dr. Futcher will provide independent expertise and strategic ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Medical Market Analysis 2016 - Forecast to 2022" report ... The report contains up to date financial data derived from ... of major trends with potential impact on the market during ... market segmentation which comprises of sub markets, regional and country ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World ... with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
Breaking Medicine News(10 mins):